Smartphone program aims to shield breast cancer Patients' hearts
NCT ID NCT06518200
First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 18 times
Summary
This study tests a daily, personalized program supported by a mobile app to prevent heart damage caused by breast cancer treatments like chemotherapy and radiation. About 102 women with early-stage breast cancer will use the app, which uses artificial intelligence to tailor exercise and monitoring. The goal is to reduce heart side effects and improve long-term health and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Granada
Granada, 18016, Spain
Conditions
Explore the condition pages connected to this study.